Deckert PM - Search Results

1

A33scFv-green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting.

Petrausch U, Dernedde J, Coelho V, Panjideh H, Frey D, Fuchs H, Thiel E, Deckert PM. Petrausch U, et al. Among authors: deckert pm. Protein Eng Des Sel. 2007 Dec;20(12):583-90. doi: 10.1093/protein/gzm043. Epub 2007 Nov 22. Protein Eng Des Sel. 2007. PMID: 18033820

2

A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy.

Deckert PM, Renner C, Cohen LS, Jungbluth A, Ritter G, Bertino JR, Old LJ, Welt S. Deckert PM, et al. Br J Cancer. 2003 Mar 24;88(6):937-9. doi: 10.1038/sj.bjc.6600751. Br J Cancer. 2003. PMID: 12644833 Free PMC article.

3

Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.

Deckert PM, Bornmann WG, Ritter G, Williams C Jr, Franke J, Keilholz U, Thiel E, Old LJ, Bertino JR, Welt S. Deckert PM, et al. Int J Oncol. 2004 May;24(5):1289-95. Int J Oncol. 2004. PMID: 15067353

4

Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer.

Hütter G, Szélenyi H, Deckert PM, Keilholz U, Thiel E. Hütter G, et al. Among authors: deckert pm. Cancer Chemother Pharmacol. 2004 Aug;54(2):178-84. doi: 10.1007/s00280-004-0796-z. Epub 2004 Apr 28. Cancer Chemother Pharmacol. 2004. PMID: 15114411 Clinical Trial.

5

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study.

Siehl JM, Thiel E, Schmittel A, Hütter G, Deckert PM, Szelényi H, Keilholz U. Siehl JM, et al. Among authors: deckert pm. Cancer. 2005 Aug 1;104(3):611-7. doi: 10.1002/cncr.21211. Cancer. 2005. PMID: 15968689 Free article. Clinical Trial.

6

Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer.

Coelho V, Dernedde J, Petrausch U, Panjideh H, Fuchs H, Menzel C, Dübel S, Keilholz U, Thiel E, Deckert PM. Coelho V, et al. Among authors: deckert pm. Int J Oncol. 2007 Oct;31(4):951-7. Int J Oncol. 2007. PMID: 17786329

7

Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatants.

Panjideh H, Coelho V, Dernedde J, Fuchs H, Keilholz U, Thiel E, Deckert PM. Panjideh H, et al. Among authors: deckert pm. Bioprocess Biosyst Eng. 2008 Oct;31(6):559-68. doi: 10.1007/s00449-008-0203-y. Epub 2008 Feb 6. Bioprocess Biosyst Eng. 2008. PMID: 18253756

8

Surface expression of gpA33 is dependent on culture density and cell-cycle phase and is regulated by intracellular traffic rather than gene transcription.

Frey D, Coelho V, Petrausch U, Schaefer M, Keilholz U, Thiel E, Deckert PM. Frey D, et al. Among authors: deckert pm. Cancer Biother Radiopharm. 2008 Feb;23(1):65-73. doi: 10.1089/cbr.2007.0407. Cancer Biother Radiopharm. 2008. PMID: 18298330

9

Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer.

Panjideh H, Da Silva Coelho VC, Dernedde J, Bachran C, Förster GJ, Franke J, Fasold P, Fuchs H, Thiel E, Deckert PM. Panjideh H, et al. Among authors: deckert pm. Int J Oncol. 2008 Apr;32(4):925-30. Int J Oncol. 2008. PMID: 18360720

10

Targeted enzyme prodrug therapies.

Schellmann N, Deckert PM, Bachran D, Fuchs H, Bachran C. Schellmann N, et al. Among authors: deckert pm. Mini Rev Med Chem. 2010 Sep;10(10):887-904. doi: 10.2174/138955710792007196. Mini Rev Med Chem. 2010. PMID: 20560876 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters